Loading company…
Riskpilot
← Back to search
Sign in
Get full access
NORRMAN TECHNICS K/S
K/S
Active
CVR 33053878
Nybrogade 18
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2010
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2013
DKK 44,2M
+46821% vs 2012
EBITDA margin
100.0%
+46821% vs 2012
Equity ratio
31.7%
Financial strength
Net profit 2013
DKK 42,5M
+45095% vs 2012
EBITDA — year on year
DKK millions
0M
14M
28M
41M
55M
0M
2012
44M
+4400%
2013
Key figures
Annual report 2013
Revenue
DKK 44,2M
+46821%
EBITDA
DKK 44,2M
+46821%
Net profit
DKK 42,5M
+45095%
Total assets
DKK 35,8M
+1563%
Equity
DKK 11,3M
+11968%
Employees
—
—
Company information
Legal name
NORRMAN TECHNICS K/S
CVR number
33053878
Legal form
Kommanditselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. juli 2010
Share capital
—
Employees
—
VAT registered
No
Audit selected
No
Last report
2013-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en direktør.
Contact
Address
Nybrogade 18
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in København
All Denmark companies
Revenue
DKK millions
0M
13M
25M
38M
51M
0M
2012
44M
2013
EBITDA
DKK millions
0M
13M
25M
38M
51M
0M
2012
44M
2013
Income statement
DKK thousands
Item
2012
2013
Revenue
94
44.188
Staff expenses
-0
-0
EBITDA
94
44.188
Depreciation & amort.
-0
0
EBIT
94
44.188
Net financials
-0
-1.721
Profit before tax
94
42.468
Tax
-0
-0
Net profit
94
42.468
Balance sheet
DKK thousands
Item
2012
2013
Total assets
2.151
35.778
Equity
94
11.340
Long-term debt
0
5
Short-term debt
2.057
24.433
Total debt
2.057
24.438
Financial ratios
5-year trend
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
2012
2013
Equity ratio
31.7%
This company
38.2%
Market median
+17% vs market
2012
2013
Return on equity
374.5%
This company
18.4%
Market median
+1935% vs market
2012
2013
Net profit margin
96.1%
This company
8.1%
Market median
+1086% vs market
2012
2013
Asset turnover
1.24×
This company
1.12×
Market median
+11% vs market
2012
2013
Debt / equity
2.16×
This company
0.62×
Market median
-248% vs market
2012
2013
Annual reports & filings
Annual report 2013
Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
View
PDF
Annual report 2012
Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
LC
LEGUM COMPANY S.A.
Stakeholder
Stakeholder
2013
—
—
IE
Irene Ellert
Management
Management
2010
—
—
AM
Arunas Masenas
Management
Management
2011
—
—
BL
BROOMGELD LTD., VASILI MICHAILIDI & IRAKLEUS
Stakeholder
Stakeholder
2010
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of NORRMAN TECHNICS K/S also hold positions in
0
other companies.
Person
Role here
Other companies
LEGUM COMPANY S.A.
Stakeholder
0 companies
Irene Ellert
Management
0 companies
Arunas Masenas
Management
0 companies
BROOMGELD LTD., VASILI MICHAILIDI & IRAKLEUS
Stakeholder
0 companies